Clinical Trial Update: To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial comparing inhaled insulin with subcutaneous insulin in people with Type 2 diabetes to assess effects on lung function and gluco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin)
• Subcutaneous insulin (insulin)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED